TABLE 1

Clinical and Angiographic Data

VariableGroup
A1 (n = 42)A2* (n = 30)B1 (n = 25)B2* (n = 26)
Age (y)53 ± 1056 ± 956 ± 756 ± 9
M/F39/328/223/224/2
History (mo.)44 ± 4867 ± 5048 ± 5057 ± 65
Smoking (%)21 (50)12 (40)12 (48)11 (42)
Hypertension (%)21 (50)12 (40)12 (48)7 (27)
Diabetes (%)8 (19)2 (7)3 (12)3 (12)
Hyperlipidemia (%)7 (17)7 (23)7 (28)5 (19)
Family history of CAD (%)7 (17)6 (20)7 (28)5 (19)
Previous MI
 Q-wave MI (%)33 (79)23 (77)19 (76)20 (77)
 Anterior MI (%)28 (67)20 (67)19 (76)18 (69)
 Aneurysm (%)13 (31)9 (30)10 (40)9 (35)
 NYHA class III–IV (%)20 (48)16 (53)14 (56)14 (54)
 CCS class II–IV (%)37 (88)25 (83)22 (88)22 (85)
EF (%)36 ± 535 ± 836 ± 634 ± 6
EDD (mm)62 ± 861 ± 760 ± 461 ± 6
Coronary angiography
 IVD (%)5 (12)4 (13)3 (12)2 (8)
 MVD (%)37 (88)26 (87)22 (88)24 (92)
  • * P > 0.05 (group A1 vs. group A2, group B1 vs. group B2).

  • NYHA heart failure class.

  • CCS angina class.

  • IVD = single-vessel disease; MVD = multiple-vessel disease.